| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ac6301f3c15d076f51475abf2fe1e0ec
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bc5d46e2534c71894312c218081ec42d |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/Y10S530-809
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-56
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-21
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2039-505 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-18 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-06 |
| filingDate |
2003-06-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c328898b6f61ac87e1f4622dc68b650
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9fd5f9b67983291be025c7ae38eccac1 |
| publicationDate |
2005-03-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
EP-1518926-A1 |
| titleOfInvention |
HUMAN IgM ANTIBODY LYSING ACTIVATED LYMPHOCYTES UNDER MEDIATION BY HOMOLOGOUS COMPLEMENT |
| abstract |
A human IgM monoclonal antibody responding to HIV-infected cells too, which is characterized by lysing activatednhuman lymphocytes, etc. under the mediation by a homologous human complement, is obtained. Using the thus obtained monoclonalnantibody, it is intended to provide an immune reaction controlling remedy, etc. containing the human IgM monoclonal antibodynwhich responds specifically to activated lymphocytes and induces cell lysis under the mediation by a homologous complement. Usingnthe human IgM monoclonal antibody responding to activated human lymphocytes, it is also intended to provide an HTV remedy, etc.n characterized by lysing and eliminating activated lymphocytes to thereby treat transplantation rejection and autoimmune diseasesncaused by an over-response of T lymphocytes as well as HIV infection |
| priorityDate |
2002-07-01-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |